CAS 141-01-5|Iron(II) fumarate
| Common Name | Iron(II) fumarate | ||
|---|---|---|---|
| CAS Number | 141-01-5 | Molecular Weight | 169.901 |
| Density | 2.435 | Boiling Point | / |
| Molecular Formula | C4H2FeO4 | Melting Point | >280°C |
| MSDS | ChineseUSA | Flash Point | / |
Names
| Name | Ferrous fumarate |
|---|---|
| Synonym | More Synonyms |
Iron(II) fumarate BiologicalActivity
| Description | Iron(II) fumarate (Ferrous fumarate) is the iron(II) salt of fumaric acid. Iron(II) fumarate is an orally active dietary supplement and has the potential for iron deficiency anemia treatment[1][2][3]. |
|---|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Metabolic Disease |
| References | [1]. Zlotkin S, et al. Treatment of anemia with microencapsulated ferrous fumarate plus ascorbic acid supplied as sprinkles to complementary (weaning) foods. Am J Clin Nutr. 2001 Dec;74(6):791-5. [2]. Zlotkin S, et al. Use of microencapsulated iron(II) fumarate sprinkles to prevent recurrence of anaemia in infants and young children at high risk. Bull World Health Organ. 2003;81(2):108-15. [3]. Vesna D. Nikolić, et al. The synthesis and characterization of iron(II): Gluconate. Advanced technologies. 3(2) (2014) 16-24. |
Chemical & Physical Properties
| Density | 2.435 |
|---|---|
| Melting Point | >280°C |
| Molecular Formula | C4H2FeO4 |
| Molecular Weight | 169.901 |
| Exact Mass | 169.930252 |
| PSA | 52.60000 |
| InChIKey | PMVSDNDAUGGCCE-TYYBGVCCSA-L |
| SMILES | O=C([O-])C=CC(=O)[O-].[Fe+2] |
| Stability | Stability |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 400 mg/kg
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - dyspnea Gastrointestinal - nausea or vomiting
- REFERENCE :
- HUTODJ Human Toxicology. (Macmillan Press Ltd., Houndmills, Basingstoke, Hants., RG 21 2XS, UK) V.1- 1981- Volume(issue)/page/year: 7,281,1988
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3850 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,683,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 185 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,683,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 500 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,683,1982
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1570 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AJMSA9 American Journal of the Medical Sciences. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) New series: V.1- 1841- Volume(issue)/page/year: 241,296,1961
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 480 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AJMSA9 American Journal of the Medical Sciences. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) New series: V.1- 1841- Volume(issue)/page/year: 241,296,1961 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 1 mg(Fe)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,138,1971 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-DENMARK:TWA 1 mg(Fe)/m3 JAN 1993 OEL-FINLAND:TWA 1 mg(Fe)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 1 mg(Fe)/m3 JAN 1993 OEL-SWITZERLAND:TWA 1 mg(Fe)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 1 mg(Fe)/m3;STEL 2 mg(Fe)/m3 JAN 1993 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80414 No. of Facilities: 129 (estimated) No. of Industries: 2 No. of Occupations: 9 No. of Employees: 9131 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80414 No. of Facilities: 429 (estimated) No. of Industries: 3 No. of Occupations: 18 No. of Employees: 3859 (estimated) No. of Female Employees: 1728 (estimated)
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Risk Phrases | R36/37/38 |
| Safety Phrases | S22-S36/37/39 |
| RIDADR | NONH for all modes of transport |
| RTECS | LT1950000 |
| HS Code | 2917190090 |
Customs
| HS Code | 2917190090 |
|---|---|
| Summary | 2917190090 acyclic polycarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
Articles27
More Articles| Effectiveness evaluation of the food fortification program of Costa Rica: impact on anemia prevalence and hemoglobin concentrations in women and children. Am. J. Clin. Nutr. 101(1) , 210-7, (2015) Food fortification is one approach for addressing anemia, but information on program effectiveness is limited.We evaluated the impact of Costa Rica's fortification program on anemia in women aged 15-4... | |
| Rapid recovery time of hemoglobin level in female regular blood donors with ferrous fumarate and high dose of ascorbic acid supplement. J. Med. Assoc. Thai. 96(2) , 165-71, (2013) Iron deficiency anemia has occurred more frequently in female than male regular blood donors. Iron supplement is necessary for maintaining the hemoglobin level. A combination with ascorbic acid increa... | |
| [Effect of iron supplementation on iron deficiency anemia of childbearing age women in Shanghai]. Wei Sheng Yan Jiu 41(1) , 51-5, (2012) To investigate the effect of iron supplementation on iron deficiency anemia of childbearing age women, and to find out the optimal amount of iron intake for maintaining their health.74 childbearing ag... |
Synonyms
| firon |
| fumafer |
| Iron(II) fumarate |
| [But-2-enedioato(2-)-κO,O]iron |
| feostat |
| Fumaric acid, iron salt |
| ircon |
| Iron, [2-butenedioato(2-)-κO,κO]- |
| galfer |
| EINECS 205-447-7 |
| Iron(2+) (2E)-2-butenedioate |
| 2-Butenedioic acid, iron(2+) salt, (2E)- (1:1) |
| MFCD00058315 |
| Ferrous Fumarate |
| Iron(2+) (2E)-but-2-enedioate |
| ferrone |
| feroton |
| fumar-f |
| fumar |
| Fumar F |
| cpiron |
